A detailed history of Truvestments Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Truvestments Capital LLC holds 565 shares of LLY stock, worth $449,553. This represents 0.14% of its overall portfolio holdings.

Number of Shares
565
Previous 415 36.14%
Holding current value
$449,553
Previous $375,000 33.33%
% of portfolio
0.14%
Previous 0.15%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$772.14 - $960.02 $115,821 - $144,003
150 Added 36.14%
565 $500,000
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $3,624 - $4,545
5 Added 1.22%
415 $375,000
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $21,735 - $29,964
50 Added 13.89%
410 $220,000
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $1,553 - $1,824
-5 Reduced 1.37%
360 $123,000
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $7,074 - $8,242
22 Added 6.41%
365 $133,000
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $95,604 - $112,253
343 New
343 $111,000
Q1 2022

May 02, 2022

SELL
$234.69 - $291.66 $80,498 - $100,039
-343 Closed
0 $0
Q2 2021

Aug 12, 2021

SELL
$180.55 - $233.54 $35,929 - $46,474
-199 Reduced 36.72%
343 $79,000
Q1 2021

May 18, 2021

BUY
$164.32 - $212.72 $32,699 - $42,331
199 Added 58.02%
542 $101,000
Q4 2020

Feb 17, 2021

BUY
$130.46 - $172.63 $18,786 - $24,858
144 Added 72.36%
343 $58,000
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $23,248 - $26,891
-159 Reduced 44.41%
199 $29,000
Q2 2020

Aug 06, 2020

BUY
$136.42 - $164.18 $21,690 - $26,104
159 Added 79.9%
358 $58,000
Q1 2020

May 07, 2020

BUY
$119.05 - $147.35 $23,690 - $29,322
199 New
199 $27,000
Q4 2019

Jan 29, 2020

SELL
$106.92 - $132.43 $28,654 - $35,491
-268 Closed
0 $0
Q2 2019

Jul 15, 2019

SELL
$110.79 - $129.32 $20,496 - $23,924
-185 Reduced 40.84%
268 $30,000
Q1 2019

Apr 12, 2019

SELL
$111.31 - $131.02 $3,450 - $4,061
-31 Reduced 6.4%
453 $59,000
Q3 2018

Oct 22, 2018

BUY
$85.86 - $107.31 $41,556 - $51,938
484 New
484 $52,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Truvestments Capital LLC Portfolio

Follow Truvestments Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Truvestments Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Truvestments Capital LLC with notifications on news.